Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...
With the advent of GLP-1 drugs, perspectives about weight management are changing. Ted Kyle hopes the food industry can make some changes, too, to better serve all consumers.
People are buying healthier snacks and household food bills are dropping as GLP-1 weight-loss drugs alter eating habits.
In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...
There are so many false promises online when it comes to losing weight. Here are my top weight loss technologies that ...
Shares of Allurion Technologies on Friday surged a day after the company said it received positive results about the effectiveness of its gastric balloon in combination with a low dose of the ...
GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.
GLP-1 RA use is associated with better graft and patient survival among kidney transplant recipients with diabetes.
While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...
The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...
Q: My very experienced cardiologist noted recently that for many patients, including me, losing weight improves many heart health issues. It really doesn’t matter how the weight loss happens, as long ...
Allurion Technologies (ALUR) announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results